// App-Quantinova.ai

: Bronchoprotective tolerance with indacaterol is not modified by concomitant tiotropium in persistent asthma

Researchers

Presenter

  • Sunny Jabbal

Principal Investigators

  • Arvind Manoharan

  • Brian Lipworth

Medical Centers

  • Scottish Centre for Respiratory Research, Ninewells Hospital and Medical School, Dundee, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Asthma

Biomarkers

  • N/A

Drug/Treatment

  • indacaterol

  • Tiotropium bromide

Outcome

  • N/A

Study Design

  • Randomized

  • Cross Over

  • Open Label

Phase

  • NA

Study Id's

  • NCT02039011

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved